Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Olon S.p.A. Expands Microbial GMP Capabilities | Contract Pharma

What are you searching for?

Sign in
Breaking News

Olon S.p.A. Expands Microbial GMP Capabilities

Investing in new GMP manufacturing facility in Capua, Italy

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Olon S.p.A., an active pharmaceutical ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, has started the construction of a new GMP manufacturing facility at its microbial CDMO facility located in Capua, Italy.
 
“I am pleased to announce the start of this GMP capacity expansion just within 6 months after the acquisition of Capua BioServices,” said Paolo Tubertini, chief executive officer, Olon. “This truly confirms the real opportunity to accelerate growth in Olon’s CDMO service positioning and to be recognized as European Leader in the CDMO of microbial fermentation.”
 
The construction of this new GMP facility is associated to a long-term strategic partnership with a large pharmaceutical company. The engineering project is designed to support the manufacture of multiple products, up to commercial scale. It is a great addition to Olon’s recent successes in the development and execution of GMP as well as food-grade engineering projects; from first concept to final commissioning, based on green-field and brown-field, under extremely challenged timelines.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics